Summary and Info
Content: Similarities and differences in the pathophysiology of asthma and COPD / Christian Virchow -- Glucocorticoids : pharmacology and mechanisms / Peter Barnes -- Inhaled corticosteroids? clinical effects in asthma and COPD / Paul O'Byrne -- LABAS : pharmacology, mechanisms and interaction with anti-inflammatory treatments / Gary Anderson -- Long and ultra-long acting beta-2-agonists / Mario Cazzola -- The safety of long-acting beta agonists and the development of combination therapies for asthma and chronic obstructive pulmonary disease / Eugene Bleecker -- Inhaled combination therapy with glucocorticoids and long-acting beta-2-agonists in asthma and COPD, current and future perspectives / Jan Lotvall -- Novel anti-inflammatory treatments for asthma and COPD / Ian Adcock -- Novel biologicals alone and in combination in asthma and allergy / William Busse -- Anti-infective treatments in asthma and COPD / Jonathan D.R. Macintyre & Sebastian L. Johnston -- Long acting muscarinic antagonists in asthma and COPD / Denis O'Donnell -- Phosphodiesterase inhibitors in obstructive lung disease / Jan Lotvall -- Biological therapies in development for COPD / Riccardo Polosa -- Triple therapy?, in the management of chronic obstructive lung disease (COPD). The value of combination treatment with inhaled steroid, long acting anticholinergicbronchodilator and long acting beta 2 agonist bronchodilator in COPD / Ronald Dahl.
More About the Author
Jan Lötvall (also spelled Lotvall, born 7 December 1956) is a Swedish clinical allergist and scientist working on translational research primarily in the field of asthma.
Review and Comments
Rate the Book
Advances in combination therapy for asthma and COPD 0 out of 5 stars based on 0 ratings.